Quick Answer
Context Therapeutics Inc. reported Common Stock Shares Outstanding of 91.88 million shares for the year ending 2025.
- Context Therapeutics Inc. showed an increase of +2.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Context Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Context Therapeutics Inc.'s Common Stock Shares Outstanding has grown by 27,592.1%.
- Historical annual values: Fiscal year 2025: 91.88 million shares | Fiscal year 2024: 89.70 million shares | Fiscal year 2023: 15.97 million shares | Fiscal year 2022: 15.97 million shares | Fiscal year 2021: 15.97 million shares | Fiscal year 2020: 331,789 shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: